|1.||Marcovina, Santica M: 16 articles (12/2015 - 03/2002)|
|2.||Koschinsky, Marlys L: 11 articles (08/2013 - 07/2002)|
|3.||Ryan, Robert O: 10 articles (12/2015 - 08/2008)|
|4.||Kronenberg, Florian: 10 articles (07/2014 - 02/2002)|
|5.||Lingenhel, Arno: 9 articles (04/2009 - 05/2003)|
|6.||Dieplinger, Hans: 9 articles (04/2009 - 06/2002)|
|7.||Tso, Patrick: 8 articles (12/2015 - 07/2004)|
|8.||Forte, Trudy M: 8 articles (04/2013 - 08/2008)|
|9.||Kronenberg, F: 7 articles (10/2015 - 01/2000)|
|10.||Berglund, Lars: 7 articles (08/2011 - 01/2002)|
08/01/2005 - "We propose that high levels of apo(a)/Lp(a), perhaps acting via a specific cell-surface binding domain, inhibit hepatic clearance of remnants, leading to high plasma levels of RLPs and markedly enhanced atherosclerosis. "
09/01/2000 - "Experimental in vitro and in vivo studies favor apoA-IV to be protective against the development of atherosclerosis. "
01/01/2015 - "Thus, we generated a human apo(a)-transgenic miniature pig that can be used as a model system to study advanced atherosclerosis related to human disease. "
04/01/2015 - "Little is reported on the effect of apoA-V on postprandial plasma TG, an independent predictor for atherosclerosis. "
01/01/2015 - "The anatomical and physiological similarities between the swine and human cardiovascular systems will make this pig model a valuable source of information on the role of apo(a) in the formation of atherosclerosis, as well as the mechanisms underlying vascular health and disease. "
07/01/2004 - "apoA-IV knockout mice exhibited a significantly greater inflammatory response to DSS than did their WT littermates; this greater susceptibility to DSS-induced inflammation was reversed upon exogenous administration of apoA-IV to knockout mice. "
04/01/2008 - "These findings indicate that proinflammatory conditions result in a selective increase in medium-sized apo(a) levels in African-Americans and suggest that inflammation-associated events may contribute to the interethnic difference in Lp(a) levels between African-Americans and Caucasians."
04/01/2008 - "We investigated the effect of inflammation on allele-specific apo(a) levels in African-Americans and Caucasians. "
11/05/1998 - "Thus, factors that modulate inflammation and inflammation-mediated fragmentation of Lp(a)/apo(a) may play an important role in the cardiovascular pathogenicity of Lp(a). "
01/01/2009 - "The purpose of this study was to evaluate the role of apo(a) in inflammation in vivo using apo(a) transgenic mice and to determine if effects are plasminogen-dependent using backgrounds that are either plasminogen-replete or plasminogen-deficient. "
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
09/01/2006 - "We investigated the apoA-V/TG relationship and the association of apoA-V with coronary artery disease (CAD) risk by determining serum apoA-V levels and genotypes in a nested case-control (n = 1,034/2,031) study. "
04/14/2006 - "The purpose of the present study was to analyse the association of the degree of coronary atherosclerosis with Lp(a) levels and apo(a) polymorphism in a large group of type 2 diabetic patients. "
06/01/2001 - "The purpose of this study was to search for mutations in the apo(a) kringle IV type 10 which could alter the LBS activity of Lp(a) from patients with coronary artery disease. "
05/01/1999 - "Multiple Cox proportional hazards regression analysis found age and the apo(a) phenotype to be the best predictors for coronary events during the observation period, independent of whether patients with a preexisting coronary artery disease or an age >65 yr at the study entry or both were excluded from the analysis. "
05/01/1999 - "In this study, it was determined whether Lp(a) and/or the genetically determined apo(a) phenotype are risk predictors for the development of coronary artery disease in these patients. "
|4.||Cardiovascular Diseases (Cardiovascular Disease)
06/30/2013 - "Improvements in the ability to readily and reliably measure the kinetics of apo(a) using a stable isotope labeled tracer is expected to facilitate studies of the role of Lp(a) in cardiovascular disease. "
05/01/2014 - "The apo(a) component of Lp(a) is encoded by LPA, and the Met allele of the LPA Ile4399Met polymorphism is associated with elevated Lp(a) levels and cardiovascular disease risk. "
08/01/2013 - "Our data reveal unique and potent activities of apo(a) that may negatively influence SMC remodelling in cardiovascular disease. "
08/01/2004 - "Baseline Lp(a) concentration and apo(a) size were determined in 195 men who subsequently developed angina and in 195 men who remained free of cardiovascular disease for 5 years. "
07/01/2003 - "We studied the association of Lp(a) level and apo(a) size with prevalent atherosclerotic cardiovascular disease (ASCVD) in 871 incident dialysis patients (261 blacks, 565 whites, 45 other). "
08/01/2009 - "Duration of CAD, Homa-IR, and diabetes mellitus were the independent risk factors for CAD found in the present study, while ApoA was the protective one."
08/01/1999 - "Therefore, the apo(a) gene, located at 6q26-27, might be a susceptibility gene for Type I diabetes mellitus which is supported by recently published studies reporting evidence for linkage of this region (6q27) with Type I diabetes mellitus. "
01/01/1998 - "To study the implications of Lp(a), we examined plasma Lp(a) levels and molecular weights of apo(a) in patients with cerebrovascular disease (CVD) or diabetes mellitus (DN). "
01/01/1998 - "To study the implications of LP(a), we examined plasma LP(a) levels and molecular weights of APO(a) in patients with cerebrovascular disease (CVD) or diabetes mellitus (DM). "
08/01/1999 - "We investigated Lp(a) plasma concentrations and apo(a) phenotypes in 327 patients with Type I diabetes mellitus (disease duration 1-61 years) and in 200 control subjects matched for age and sex. "
|1.||Apolipoprotein A-I (Apolipoprotein A1)
|2.||Apoprotein(a) (Apolipoprotein (a))
|3.||Protein Isoforms (Isoforms)
|1.||Blood Component Removal (Apheresis)
|2.||Renal Dialysis (Hemodialysis)
|4.||Renal Replacement Therapy (Therapies, Renal Replacement)